Alchemab

Developer of antibody therapeutics for treating oncology and neurodegenerative conditions

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups8 employees language alchemab.com

Registered entities

Social engagement

Social engagement: 11.3K social following, 7 posts in the last 12 months — below the industry typical range.

Recent activity

17 Mar 2026
Leadership hire
Chief Business Officer
16 Jan 2026
Recognition
1 Oct 2025
Recognition
Coming soon